Sanjeev Majoo is VP Strategic Sourcing & Procurement and Head of Commercial and Markets Procurement at Bristol Myers Squibb. He has significant experience in leading and enabling business transformation, evolution of commercial products portfolio and markets, manufacturing, supply chain and R&D product development. He joined BMS in 2012 as Executive Director, External Manufacturing and Pharmaceutical Development procurement. In 2014, Sanjeev was appointed VP and Head of Global Product Development and Supply procurement. In 2018, Sanjeev was appointed to as Head of Commercial and International Markets procurement.
Prior to BMS, Sanjeev led the Global Strategic Sourcing organization for Manufacturing Operations and Process Development at Amgen in California. Prior to that, he was in a variety of process development, manufacturing, engineering and procurement roles at Merck in New Jersey. Sanjeev holds an MBA in Finance from New York University and a Ph.D. in Chemical Engineering from University of Michigan.
The COVID-19 pandemic caught many companies unprepared—and has exposed shortcomings in their mechanisms to plan for and mitigate supply fluxes during severe disruptions. It has also revealed a lack of centralized and coordinated visibility in risk monitoring. During this time of crisis, CPOs have seen that strategic sourcing has been the pillar of strength to manufactures and retailer. As they look ahead to the post-COVID era and what that will look like, they are ensuring their organizations’ abilities to respond to future unexpected challenges with confidence and insight. This session we focus on:
Check out the incredible speaker line-up to see who will be joining Sanjeev.
Download The Latest Agenda